Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10,630,964
-
Total 13F shares
-
5,282,295
-
Share change
-
+257,576
-
Total reported value
-
$45,322,000
-
Price per share
-
$8.58
-
Number of holders
-
14
-
Value change
-
+$2,352,286
-
Number of buys
-
7
-
Number of sells
-
7
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q4 2020
As of 31 Dec 2020,
NEPHROS INC - Common Stock - $0.001 par value (NEPH) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,282,295 shares.
The largest 10 holders included
WEXFORD CAPITAL LP, Cowen Prime Services LLC, Samjo Capital LLC, BARD ASSOCIATES INC, Parkman Healthcare Partners LLC, VANGUARD GROUP INC, HighTower Advisors, LLC, BLAIR WILLIAM & CO/IL, MILLENNIUM MANAGEMENT LLC, and BlackRock Inc..
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.